Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

By Anne Villeneuve, Stephanie Hill

Featured

Stephen J. Schuster

Jun 19, 2017

Interim results of the JULIET trial of CTL019 in R/R DLBCL

More about...

Aggressive B-cell lymphomas Diffuse large B-cell lymphoma ICML 2017 JULIET Tisagenlecleucel

Why patients with large B-cell lymphoma fail CAR T-cell therapy & how to manage them

This article explores the potential reasons for relapse following CAR T-cell therapy and the management strategies for this population of large B-cell lymphoma...

Sep 13, 2019

Why patients with large B-cell lymphoma fail CAR T-cell therapy & how to manage them

This article explores the potential reasons for relapse following CAR T-cell therapy and the management strategies...

Sep 13, 2019

Educational theme: Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL

Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL

Aug 5, 2019

Educational theme: Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL

Chimeric antigen receptor (CAR) T-cell therapies in DLBCL and CLL

Aug 5, 2019

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Stephen J. Schuster | ICML 2017 | Interim results of the JULIET trial of CTL019 in R/R DLBCL

By Anne Villeneuve, Stephanie Hill

Featured

Stephen J. Schuster

Jun 19, 2017

More about...

Related articles

Sep 13, 2019

Sep 13, 2019

Aug 5, 2019

Aug 5, 2019

Newsletter